1. Home
  2. DJTWW vs TNDM Comparison

DJTWW vs TNDM Comparison

Compare DJTWW & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trump Media & Technology Group Corp.

DJTWW

Trump Media & Technology Group Corp.

HOLD

Current Price

$6.70

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

HOLD

Current Price

$18.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DJTWW
TNDM
Founded
2021
2006
Country
United States
United States
Employees
29
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
DJTWW
TNDM
Price
$6.70
$18.84
Analyst Decision
Buy
Analyst Count
0
17
Target Price
N/A
$24.35
AVG Volume (30 Days)
172.0K
1.3M
Earning Date
04-02-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,369,800.00
$1,007,001,000.00
Revenue This Year
N/A
$8.59
Revenue Next Year
N/A
$10.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.87
52 Week Low
$6.53
$9.98
52 Week High
$44.83
$37.71

Technical Indicators

Market Signals
Indicator
DJTWW
TNDM
Relative Strength Index (RSI) 51.11 37.33
Support Level $5.19 $18.90
Resistance Level $6.31 $19.53
Average True Range (ATR) 0.51 1.02
MACD -0.08 -0.13
Stochastic Oscillator 65.37 7.64

Price Performance

Historical Comparison
DJTWW
TNDM

About DJTWW Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: